Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter LAG3 Antikörper

LAG3 Reaktivität: Maus IP, FACS, BP Wirt: Ratte Monoclonal C9B7W unconjugated Recombinant Antibody
Produktnummer ABIN7072736
  • Target Alle LAG3 Antikörper anzeigen
    LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
    Antikörpertyp
    Recombinant Antibody
    Reaktivität
    • 101
    • 34
    • 9
    • 3
    • 3
    • 3
    • 1
    • 1
    Maus
    Wirt
    • 58
    • 42
    • 8
    • 4
    • 2
    • 1
    Ratte
    Klonalität
    • 57
    • 55
    • 2
    Monoklonal
    Konjugat
    • 67
    • 8
    • 6
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser LAG3 Antikörper ist unkonjugiert
    Applikation
    • 79
    • 45
    • 44
    • 35
    • 34
    • 30
    • 14
    • 13
    • 12
    • 11
    • 11
    • 9
    • 5
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Immunoprecipitation (IP), Flow Cytometry (FACS), Blocking Peptide (BP)
    Verwendungszweck
    Anti-LAG-3 [C9B7W], Rat IgG1, kappa
    Spezifität
    This antibody is specific for an epitope in the D2 domain of murine LAG-3.
    Produktmerkmale

    Original Species of Ab: Rat

    Original Format of Ab: IgG1

    Aufreinigung
    Protein A affinity purified
    Immunogen
    This antibody was raised by immunising Lewis rats with a murine LAG-3:Ig fusion protein.
    Klon
    C9B7W
    Isotyp
    IgG1 kappa
    Top Product
    Discover our top product LAG3 Primärantikörper
  • Applikationshinweise
    This antibody has been used in flow cytometric analysis of splenocytes (Workman et al, 2005), T cell hybridomas expressing wild-type or chimeric CD4:murine LAG-3 (Workman et al, 2002) and CD4+ regulatory T cells (Chien et al, 2017). It has also been used in immunoprecipitation analysis of murine T hybridoma 3A9 cells transduced with murine LAG-3 (Li et al, 2004). This antibody blocks LAG-3 function in vitro, inhibiting antigen-induced IL-2 production in LAG-3-expressing T cell hybridomas, but does not block LAG-3:MHC class II interaction (Workman et al, 2002). Treatment with this antibody also blocks LAG-3 function in vivo, leading to accelerated homeostatic expansion of WT T cells (Workman et al, 2005). Administration of this LAG-3-blocking antibody, in combination with PD-L1 blockade, synergistically improves the survival of lymphodepleted myeloma-bearing mice (Jing et al, 2015).
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    1 mg/mL
    Buffer
    PBS with 0.02 % Proclin 300.
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Target
    LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
    Andere Bezeichnung
    Lag3 (LAG3 Produkte)
    Hintergrund
    CD223, LAG3, Lymphocyte activation gene 3 protein
    UniProt
    Q61790
    Pathways
    Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
Sie sind hier:
Chat with us!